Although additional alterations in the KRAS gene in JMML patients have been described as a driver of sAML transformation20, the percentage of identified cells with KRAS LOH in patient 2 was significantly lower than the percentage of blast cells at the time of scDNA-seq. Here, KRAS is linked to juvenile myelomonocytic leukemia.